Medizinische Universität Wien

Seizure outcomes following epilepsy surgery in pediatric and young adult patients with high-grade brain tumors: Results from a European survey (2025) Lersch R, Hartlieb T, Pieper T, Kudernatsch M, Hofer W, Barba C, Guerrini R, et al. Journal article Preferred Working Time Models and Equal Opportunities in Gynecology and Obstetrics: Results of the Systematic Trinational FARBEN Survey (2025) Tauber N, Amann N, Foessleitner P, Klee A, Becker C, Kiblawi R, Göpfert M, et al. Journal article Personality Functioning in Inpatients With Eating Disorders: Association With Symptom Severity and Treatment Outcome (2025) Heinzmann S, Etzler S, Hartmann A, Klein EM, Herpertz S, Pape M, Heinzmann S, et al. Journal article Factors Associated With Persisting Olfactory Dysfunction After COVID-19 (2025) Prem B, Liu DT, Boehme K, Maurer MT, Renner B, Mueller CA Journal article The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey (2025) Johansen JG, Jürgenliemk-Schulz IM, Haddad H, Hannoun-Levi JM, Hellebust TP, Guix B, Loessl K, et al. Journal article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7) (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article, Erratum Obesity in European nursing homes participating in nutritionDay 2016–2021—Prevalence and resident characteristics (2024) Galicia Ernst I, Worf I, Tarantino S, Hiesmayr M, Volkert D Journal article Hodgkin lymphoma: hypodense lesions in mediastinal masses (2024) Damek A, Kurch L, Franke FC, Attarbaschi A, Beishuizen A, Cepelova M, Ceppi F, et al. Journal article Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn’s disease and ulcerative colitis included in randomised controlled trials (2024) Peyrin‐Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola , Jahnsen J, et al. Journal article